CBIO
CRESCENT BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$12.36
+4.39%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$11.91
From 52W high−54.19%
Volume230691.00
Market cap$459.10M
P/E (TTM)—
P/S (TTM)38.6x
Div yield—
Key dataOct 19, 2026
Open
$11.91
From 52W high
−54.19%
Volume
230691.00
Market cap
$459.10M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.8x
P/E (TTM)
—
RSI (14)
34.4
MomentumView details →
1D Return
+4.39%
YTD Return
+4.38%
Similar companies
Latest newsMore news →
Crescent Biopharma approved options to purchase an aggregate of 81,525 ordinary shares for six non-executive employees as inducement awards.13d agoCrescent Biopharma received FDA clearance of its IND application for CR-002, a PD-L1-targeted topoisomerase inhibitor ADC for the treatment of solid tumors.15d agoCrescent Biopharma granted options to purchase an aggregate of 31,200 ordinary shares to two non-executive employees as equity inducement awards under its 2025 Employment Inducement Incentive Award Plan.24d ago